Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study
Welford, Richard W D, Garzotti, Marco, Marques Lourenço, Charles, Mengel, Eugen, Marquardt, Thorsten, Reunert, Janine, Amraoui, Yasmina, Kolb, Stefan A, Morand, Olivier, Groenen, Peter
Published in PloS one (05.12.2014)
Published in PloS one (05.12.2014)
Get full text
Journal Article
A nonsmooth approach to envelope theorems
Morand, Olivier, Reffett, Kevin, Tarafdar, Suchismita
Published in Journal of mathematical economics (01.12.2015)
Published in Journal of mathematical economics (01.12.2015)
Get full text
Journal Article
A qualitative approach to Markovian equilibrium in infinite horizon economies with capital
Mirman, Leonard J., Morand, Olivier F., Reffett, Kevin L.
Published in Journal of economic theory (01.03.2008)
Published in Journal of economic theory (01.03.2008)
Get full text
Journal Article
Enhanced Synthesis of the Oxysterol 24(S),25-Epoxycholesterol in Macrophages by Inhibitors of 2,3-Oxidosqualene:Lanosterol Cyclase: A Novel Mechanism for the Attenuation of Foam Cell Formation
Rowe, Andrea H, Argmann, Carmen A, Edwards, Jane Y, Sawyez, Cynthia G, Morand, Olivier H, Hegele, Robert A, Huff, Murray W
Published in Circulation research (17.10.2003)
Published in Circulation research (17.10.2003)
Get full text
Journal Article
The monotopic membrane protein human oxidosqualene cyclase is active as monomer
Ruf, Armin, Müller, Francis, D’Arcy, Brigitte, Stihle, Martine, Kusznir, Eric, Handschin, Corinne, Morand, Olivier H, Thoma, Ralf
Published in Biochemical and biophysical research communications (05.03.2004)
Published in Biochemical and biophysical research communications (05.03.2004)
Get full text
Journal Article
Synthesis and Structure−Activity Studies of Novel Orally Active Non-Terpenoic 2,3-Oxidosqualene Cyclase Inhibitors
Dehmlow, Henrietta, Aebi, Johannes D, Jolidon, Synèse, Ji, Yu-Hua, von der Mark, Elisabeth M, Himber, Jacques, Morand, Olivier H
Published in Journal of medicinal chemistry (17.07.2003)
Published in Journal of medicinal chemistry (17.07.2003)
Get full text
Journal Article
A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low–Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content
Telford, Dawn E, Lipson, Sara M, Barrett, P Hugh R, Sutherland, Brian G, Edwards, Jane Y, Aebi, Johannes D, Dehmlow, Henrietta, Morand, Olivier H, Huff, Murray W
Published in Arteriosclerosis, thrombosis, and vascular biology (01.12.2005)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.12.2005)
Get full text
Journal Article
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement
Guérard, Nicolas, Oder, Daniel, Nordbeck, Peter, Zwingelstein, Christian, Morand, Olivier, Welford, Richard W D, Dingemanse, Jasper, Wanner, Christoph
Published in Clinical pharmacology and therapeutics (01.04.2018)
Published in Clinical pharmacology and therapeutics (01.04.2018)
Get more information
Journal Article
Generalized Envelope Theorems: Applications to Dynamic Programming
Morand, Olivier, Reffett, Kevin, Tarafdar, Suchismita
Published in Journal of optimization theory and applications (01.03.2018)
Published in Journal of optimization theory and applications (01.03.2018)
Get full text
Journal Article
Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey
Morand, Olivier, Johnson, Jack, Walter, Jerry, Atkinson, Leone, Kline, Gregory, Frey, Aline, Politei, Juan, Schiffmann, Raphael
Published in Advances in therapy (01.10.2019)
Published in Advances in therapy (01.10.2019)
Get full text
Journal Article
Long‐term survival outcomes of patients with Niemann‐Pick disease type C receiving miglustat treatment: A large retrospective observational study
Patterson, Marc C., Garver, William S., Giugliani, Robert, Imrie, Jackie, Jahnova, Helena, Meaney, F John, Nadjar, Yann, Vanier, Marie T., Moneuse, Patrick, Morand, Olivier, Rosenberg, Daniel, Schwierin, Barbara, Héron, Benedicte
Published in Journal of inherited metabolic disease (01.09.2020)
Published in Journal of inherited metabolic disease (01.09.2020)
Get full text
Journal Article
Monotone methods for markovian equilibrium in dynamic economies
Datta, Manjira, Mirman, Leonard J, Morand, Olivier F, Reffett, Kevin L
Published in Annals of operations research (01.08.2002)
Published in Annals of operations research (01.08.2002)
Get full text
Journal Article
A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat
Remenova, Tatiana, Morand, Olivier, Amato, Dominick, Chadha-Boreham, Harbajan, Tsurutani, Scott, Marquardt, Thorsten
Published in Orphanet journal of rare diseases (19.06.2015)
Published in Orphanet journal of rare diseases (19.06.2015)
Get full text
Journal Article
Oxidosqualene Cyclase (OSC) Inhibitors for the Treatment of Dyslipidemia
Henrietta Dehmlow, Ralf Thoma, Armin Ruf, Narendra Panday, Elisabeth Von Der Mark, Olivier Morand, Hans Peter Märki, Manfred Kansy, Peter Hartman, Philippe Coassolo, Alexander Chucholowski, Denise Blum-Kaelin, Johannes Aebi, Jean Ackermann, Tanja Schulz-Gasch
Published in Chimia (01.03.2005)
Published in Chimia (01.03.2005)
Get full text
Journal Article
Lucerastat, an iminosugar for substrate reduction therapy: safety, tolerability, pharmacodynamics, and pharmacokinetics in adult subjects with Fabry disease
Guérard, Nicolas, Oder, Daniel, Nordbeck, Peter, Zwingelstein, Christian, Morand, Olivier, Welford, Richard, Dingemanse, Jasper, Wanner, Christoph
Published in Molecular genetics and metabolism (01.01.2017)
Published in Molecular genetics and metabolism (01.01.2017)
Get full text
Journal Article